Found: 7
Select item for more details and to access through your institution.
The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E<sub>2</sub>-mediated relaxation.
- Published in:
- British Journal of Pharmacology, 1999, v. 126, n. 1, p. 35, doi. 10.1038/sj.bjp.0702265
- By:
- Publication type:
- Article
The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects.
- Published in:
- Diabetes & Vascular Disease Research, 2014, v. 11, n. 6, p. 440, doi. 10.1177/1479164114548027
- By:
- Publication type:
- Article
Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.
- Published in:
- European Heart Journal, 2013, v. 34, n. 32, p. 2566, doi. 10.1093/eurheartj/ehs227
- By:
- Publication type:
- Article
Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Dual Peroxisome Proliferator - Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects.
- Published in:
- Diabetes Care, 2013, v. 36, n. 10, p. 2923, doi. 10.2337/dc12-2012
- By:
- Publication type:
- Article
279-LB: NIS4, a Novel Blood Test, Can Identify "At-Risk" NASH (NAS>4 and Fibrosis>2) in T2D Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-279-LB
- By:
- Publication type:
- Article
278-LB: Type 2 Diabetes (T2D) as a Risk Factor for NASH and Significant Liver Fibrosis (F>2) in an International Cohort of 2,363 Patients with Metabolic Steatosis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-278-LB
- By:
- Publication type:
- Article